Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	NICE nod for Darzalex with lenalidomide and dexamethasone - about 1 year ago
2	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - about 2 months ago Interim ALIGN Data: Atrasentan Cuts Proteinuria in IgA Nephropathy - about 2 months ago Alternative Pathway Inhibition Makes Good in IgA Nephropathy - about 2 months ago Methotrexate Tied to Greater Risks for Older Patients With CKD - about 1 year ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 3 months ago Study: Biosimilar Etanercept Shows Equivalence With Reference Product for Rheumatoid Arthritis - 4 months ago Biosimilar Disease-Modifying Antirheumatic Drugs Show Potential Cost Savings for Rheumatoid Arthritis - 5 months ago Tirzepatide Shows Improvements in MASH Without Worsening Fibrosis - 6 months ago Brentuximab Vedotin Shows 37% Reduction in Risk of Death for DLBCL - 6 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 6 months ago FDA Approves Sarilumab for Active Polyarticular Juvenile Idiopathic Arthritis - 6 months ago Study: Belumosudil Decreased Collagen, IL-17 Levels for Skin, Oral cGVHD - 10 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 11 months ago Guideline Update: KDIGO 2024 Management of Lupus Nephritis Includes Belimumab for Triple Therapy - 11 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 12 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - about 1 year ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - about 1 year ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas - 4 months ago
5	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 4 months ago Combo Biologics for Lupus Mostly Flop - 4 months ago Medicare Lags, Medicaid Leads for Biosimilar Uptake - 5 months ago Study Confirms: No Great Options for Treating VEXAS - 7 months ago Another Study Backs Treatment for Preclinical Rheumatoid Arthritis - 10 months ago Axial SpA: Gender Gap Confirmed in TNF Inhibitor Response - about 1 year ago Novel Gout Drug Aces Mid-Stage Tests - about 1 year ago Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Disease - about 1 year ago Novel Drug OK'd for Ulcerative Colitis - about 1 year ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - 4 months ago FDA Grants Accelerated Approval of Resmetirom for Noncirrhotic Nonalcoholic Steatohepatitis With Moderate to Advanced Liver Fibrosis - 9 months ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - about 1 year ago
7	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Methotrexate for Knee Osteoarthritis; Evaluating Squamous Cell Cancers - 4 months ago
8	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	2-Drug Regimen Shows Comparable Effectiveness With 3-Drug Regimen to Treat HIV-1 - 5 months ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - about 1 year ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 6 months ago Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - 11 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 12 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - about 1 year ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - about 1 year ago Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis - about 1 year ago New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis - about 1 year ago A Novel Mechanism of Action in Treating Relapsing MS - about 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - about 1 year ago
10	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Polycystic ovary syndrome could be treated with a malaria drug - 6 months ago

Journalists covering teriflunomide